Oriental Aromatics Adjusts Valuation Amid Competitive Chemicals Sector Landscape

Oriental Aromatics, a small-cap player in the chemicals industry, has recently undergone a valuation adjustment. The company's current price stands at 365.70, reflecting a notable increase from the previous close of 331.85. Over the past year, the stock has experienced a slight decline of 1.87%, contrasting with a 9.37% return from the Sensex during the same period.
Key financial metrics for Oriental Aromatics include a PE ratio of 28.61 and an EV to EBITDA ratio of 15.52. The company's return on capital employed (ROCE) is reported at 7.40%, while the return on equity (ROE) is at 5.86%. The dividend yield is relatively low at 0.14%.

In comparison to its peers, Oriental Aromatics holds an attractive valuation, particularly when juxtaposed with companies like Gujarat Alkalies, which is classified as risky, and Neogen Chemicals, which is positioned at a higher valuation tier. Other competitors such as India Glycols and Rossari Biotech also present attractive valuations, indicating a competitive landscape within the chemicals sector.